Efficacy of pentoxifylline in Peyronie’s disease: Clinical case of a young man

  • Lucio Dell’Atti | dellatti@hotmail.com Urology Unit, Arcispedale “S. Anna”, University of Ferrara, Italy.
  • Gianni Ughi Urology Unit, Arcispedale “S. Anna”, University of Ferrara, Italy.

Abstract

Peyronie’s disease (PD) is a localized connective tissue disorder of the tunica albuginea of the penis and its surrounding tissue which results in a painful erection, penile curvature and erectile dysfunction. The great number and variety of purposed treatments for PD is in proportion to the difficulty of its management.In fact no medical treatment is currently available to cure patients with PD. Pentoxifylline (PTX) is a non specific phosphodiesterase inhibitor with anti-inflammatory properties that has been used to treat claudication. PTX has also been used to decrease inflammation and fibrosis in kidney transplants, open heart surgery, dermatological conditions and after radiation injury. With respect to penile diseases, clinical studies have suggested that PTX decreases calcification in new-onset PD. These traits make PTX an interesting potential option for PD therapy.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.
Published
2014-09-30
Info
Issue
Section
Case Reports - Andrology
Keywords:
Peyronie’s Disease, Pentoxifylline, Ultrasound, Phosphodiesterase inhibitor
Statistics
  • Abstract views: 2323

  • PDF: 1284
  • SUPPLEMENTARY MATERIAL: 327
How to Cite
Dell’Atti, L., & Ughi, G. (2014). Efficacy of pentoxifylline in Peyronie’s disease: Clinical case of a young man. Archivio Italiano Di Urologia E Andrologia, 86(3), 237-238. https://doi.org/10.4081/aiua.2014.3.237